# CORCEPT THERAPEUTICS INC (CORT) FY2026 YTD Q2 P&L / Income Statement

- Company: CORCEPT THERAPEUTICS INC (CORT)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0001628280-26-050613
- Page: https://plicit.ai/financials/cort/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/cort-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Product revenue, net**: 421,050,000 US dollars
- **Cost of sales**: 6,944,000 US dollars
- **Gross profit (calculated)**: 414,106,000 US dollars
- **Operating expenses (calculated)**: 422,407,000 US dollars
- **Income (loss) from operations**: negative 8,301,000 US dollars
- **Interest and other income**: 9,517,000 US dollars
- **Income before income taxes**: 1,216,000 US dollars
- **Income tax (expense) benefit**: negative 10,010,000 US dollars
- **Net income**: 11,226,000 US dollars
- **Hypercortisolism Products**: 373,486,000 US dollars
- **Lifyorli**: 47,564,000 US dollars
- **Research and development**: 120,155,000 US dollars
- **Selling, general and administrative**: 302,252,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.